CytomX Therapeutics
CTMX
#9040
Rank
A$0.13 B
Marketcap
$1.75
Share price
0.00%
Change (1 day)
-19.67%
Change (1 year)

Earnings for CytomX Therapeutics (CTMX)

Earnings in 2024 (TTM): A$10.31 Million

According to CytomX Therapeutics 's latest financial reports the company's current earnings are A$0.12 Billion. In 2023 the company made an earning of -A$10.4 Million, an increase over its 2022 earnings that were of -A$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CytomX Therapeutics from 2015 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$10.31 M-199.18%
2023 -A$10.4 Million-94.62%
2022 -A$0.2 Billion43.84%
2021 -A$0.14 Billion72.37%
2020 -A$77.96 Million-52.66%
2019 -A$0.17 Billion31.83%
2018 -A$0.13 Billion68.34%
2017 -A$74.2 Million-20.95%
2016 -A$93.85 Million73.99%
2015 -A$53.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion-2,108.24%๐Ÿ‡บ๐Ÿ‡ธ USA